Document is current
Any future updates will be listed below
-
Authors
Haberman, Yael https://orcid.org/0000-0003-2680-1570
Karns, Rebekah
Dexheimer, Phillip J. https://orcid.org/0000-0003-3965-6894
Schirmer, Melanie
Somekh, Judith
Jurickova, Ingrid
Braun, Tzipi
Novak, Elizabeth
Bauman, Laura
Collins, Margaret H. https://orcid.org/0000-0002-0756-5974
Mo, Angela
Rosen, Michael J.
Bonkowski, Erin https://orcid.org/0000-0003-4798-1347
Gotman, Nathan
Marquis, Alison
Nistel, Mason
Rufo, Paul A.
Baker, Susan S.
Sauer, Cary G.
Markowitz, James
Pfefferkorn, Marian D.
Rosh, Joel R.
Boyle, Brendan M.
Mack, David R.
Baldassano, Robert N.
Shah, Sapana
Leleiko, Neal S.
Heyman, Melvin B. https://orcid.org/0000-0001-7988-0220
Grifiths, Anne M.
Patel, Ashish S.
Noe, Joshua D.
Aronow, Bruce J.
Kugathasan, Subra https://orcid.org/0000-0002-8686-4189
Walters, Thomas D.
Gibson, Greg https://orcid.org/0000-0002-5352-5877
Thomas, Sonia Davis
Mollen, Kevin
Shen-Orr, Shai https://orcid.org/0000-0002-6991-7736
Huttenhower, Curtis https://orcid.org/0000-0002-1110-0096
Xavier, Ramnik J. https://orcid.org/0000-0002-5630-5167
Hyams, Jeffrey S.
Denson, Lee A. https://orcid.org/0000-0001-8045-7198
- License Information
-
More Information
Article History
Received: 17 October 2018
Accepted: 28 November 2018
First Online: 3 January 2019
Competing interests
: The authors declare no competing interest associated specifically with this work. However, the following authors report the following disclosures: Sonia Davis Thomas, independent data monitoring committee, Lycera Corporation; Margaret H. Collins, research support, Shire, Regeneron; Consultant, Allakos; Michael J. Rosen, advisory board, Celgene; David R. Mack, Shares in Biotagenics; RobertN. Baldassano, Advisory Board, Janssen, Consultant, Abbvie, Lilly, Receptors, Pfizer; Neal S. Leleiko: Consultant, Abbvie; Ashish S. Patel, Speakers Bureau Abbvie, Janssen; James Markowitz, Consultant, Janssen, UCB, Lilly; Anne M. Griffiths: Research support Abbvie, Consultant Abbvie, Janssen, Merck, Takeda, Speaker Abbvie, Janssen; Joel R. Rosh: Consultant, Abbvie, Janssen, Luitpold, UCB, Grant Funding Janssen, Abbive; Paul A. Rufo: Consultant, Shire, Leutpold, Speaker, Abbvie, Research support, TechLab; Cary G. Sauer, Consultant, Abbvie; Subra Kugathasan, Consultant, Janssen, UCB; Jennifer Strople, Consultant and speaker, Abbvie; Melvin B. Heyman, Research grants Genentech, Abbvie, Sucampo, Janssen. Jeffrey S. Hyams Advisory Board, Janssen, Consultant, Abbvie, Takeda, Lilly, Boerhinger-Ingelheim, Allergan, Astra Zeneca, Receptors, Pfizer; Lee A. Denson: Grant Support, Janssen. The following authors have nothing to disclose: Yael Haberman, Rebekah Karns, Phillip J. Dexheimer, Melanie Schirmer, Judith Somekh, Ingrid Jurickova, Tzipi Braun, Elizabeth Novak, Angela Mo, Bruce J. Aronow, Thomas D. Walters, Greg Gibson, Laura Bauman, Erin Bonkowski, Alison Marquis, Nathan Gotman, Mason Nistel, Marian D. Pfefferkorn, Susan S. Baker, Brendan M. Boyle, Sapana Shah, Joshua D. Noe, Kevin Mollen, Shai Shen-Orr, Curtis Huttenhower, Ramnik J. Xavier.
